| PERIOD ENDING | 30-Sep-03 | 30-Jun-03 | 31-Mar-03 | 31-Dec-02 | | Total Revenue | 15,385 | 16,579 | 16,300 | 14,409 | | Cost of Revenue | 10,507 | 11,665 | 10,684 | 10,019 | | | Gross Profit | 4,878 | 4,914 | 5,616 | 4,389 | | | Operating Expenses | | Research Development | 268 | 293 | 229 | 135 | | Selling General and Administrative | 6,064 | 6,599 | 6,560 | 8,754 | | Non Recurring | 502 |
-
| 248 | 1,039 | | Others | 712 | 700 | 632 | 717 | | | | Total Operating Expenses | 7,546 |
-
| 7,669 | 10,644 | | | | Operating Income or Loss | (2,667) | (2,678) | (2,053) | (6,254) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 183 | 223 | 115 | 305 | | Earnings Before Interest And Taxes | (2,485) | (2,454) | (1,938) | (5,950) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,485) | (2,454) | (1,938) | (5,950) | | Income Tax Expense | (375) | (1,237) | (1,957) | (1,985) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,110) | (1,217) | 19 | (3,964) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,110) | (1,217) | 19 | (3,964) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,110) | ($1,217) | $19 | ($3,964) |
|
0.31% Nasdaq 
0.05%
Income Statement
